Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1886
http://purl.obolibrary.org/obo/NCIT_C1886
|
|---|---|
| Preferred Name | Afeletecan Hydrochloride |
| Definitions |
The hydrochloride salt form of afeletecan, a water-soluble camptothecin derivative conjugated to a carbohydrate moiety exhibiting antineoplastic activity. Afeletecan stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex. As a consequence of the formation of this complex, both the initial cleavage reaction and religation steps are inhibited and subsequent collision of the replication fork with the cleaved strand of DNA results in inhibition of DNA replication, double strand DNA breakage and triggering of apoptosis. The peptide carbohydrate moiety of this agent stabilizes the lactone form of camptothecin in blood.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The hydrochloride salt form of afeletecan, a water-soluble camptothecin derivative conjugated to a carbohydrate moiety exhibiting antineoplastic activity. Afeletecan stabilizes the topoisomerase I-DNA covalent complex and forms an enzyme-drug-DNA ternary complex. As a consequence of the formation of this complex, both the initial cleavage reaction and religation steps are inhibited and subsequent collision of the replication fork with the cleaved strand of DNA results in inhibition of DNA replication, double strand DNA breakage and triggering of apoptosis. The peptide carbohydrate moiety of this agent stabilizes the lactone form of camptothecin in blood. |
|---|---|
| prefLabel | Afeletecan Hydrochloride
|
| label | Afeletecan Hydrochloride
|
| PDQ_Closed_Trial_Search_ID | 38705
|
| code | C1886
|
| prefixIRI | NCIT:C1886
|
| in_subset | |
| Preferred_Name | Afeletecan Hydrochloride
|
| FDA_UNII_Code | DTJ7VPW43J
|
| Contributing_Source | FDA
|
| Maps_To | Camptothecin Glycoconjugate BAY 38-3441
|
| CAS_Registry | 215604-74-3
|
| NCI_Drug_Dictionary_ID | 38705
|
| Legacy Concept Name | BAY_56-3722
|
| type | |
| ALT_DEFINITION | A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called camptothecins.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38705
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C1101785
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |